Bispecific monoclonal antiboldies increase the fibrin-specific fibrinolytic activity of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)

Title

Bispecific monoclonal antiboldies increase the fibrin-specific fibrinolytic activity of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)

 Author

Bos, R.
Nieuwenhuizen, W.
Instituut voor Verouderings- en Vaatziekten Onderzoek TNO

Publication year

1992

 Subject

Health
fibrin
monoclonal antibody
plasminogen activator
tissue plasminogen activator
urokinase
drug carrier
cell fusion
conference paper
drug binding
drug efficacy
drug megadose
endothelium cell
enzyme activity
fibrinolysis
fibrinolytic therapy
hybridoma
plasminogen activation
antibody specificity
drug effect
immunology
metabolism
Antibodies, Monoclonal
Antibody Specificity
Drug Carriers
Fibrin
Fibrinolysis
Human
Kinetics
Plasminogen Activator Inhibitor 1
Tissue Plasminogen Activator
Urinary Plasminogen Activator

 To reference this document use:

http://resolver.tudelft.nl/uuid:77b4c0b3-9b2b-4aaf-8924-606909261a52

 DOI

https://doi.org/10.1111/j.1749-6632.1992.tb51644.x

 TNO identifier

232010

 ISSN

0077-8923

 Source

Annals of the New York Academy of Sciences, 667, 428-430

 Bibliographical note

Correspondence Address: Bos, R.; Gaubius Laboratory, IVVO-TNO, PO Box 430, 2300 AK Leiden, Netherlands Chemicals/CAS: fibrin, 9001-31-4; plasminogen activator inhibitor 1, 140208-23-7; tissue plasminogen activator, 105913-11-9; urokinase, 139639-24-0; Antibodies, Monoclonal; Drug Carriers; Fibrin, 9001-31-4; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator, EC 3.4.21.68; Urinary Plasminogen Activator, EC 3.4.21.73

 Document type

article
Files
To receive the publication files, please send an e-mail request to TNO Library.